Sponsor
Pasithea Therapeutics Corp.
2110 Narcissus Court, 90291-4819, United States
About the sponsor
Pasithea Therapeutics Corp. is involved in clinical research focused on solid tumors, with attention to advanced malignancies driven by MAPK pathway alterations. Its trial activity reflects interest in oncology settings where tumor biology is shaped by specific molecular changes.
- Advanced solid tumors
- MAPK pathway-driven cancers
- RAS, NF1, and RAF mutations
- BRAF/MEK inhibition-resistant disease
The sponsor’s research interest centers on targeted cancer therapy for patients with difficult-to-treat tumor types.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.